search
Back to results

Effect of Pulmonary Rehabilitation on Perioperative Outcomes in Smoker Patients With Lung Cancer (PREPOSE)

Primary Purpose

Pulmonary Neoplasm

Status
Unknown status
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
pulmonary rehabilitation
Sponsored by
Ruijin Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Pulmonary Neoplasm focused on measuring pulmonary rehabilitation, lobectomy, smoker

Eligibility Criteria

undefined - 80 Years (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. signed consent
  2. smoker, ≥400/cigarette year
  3. surgical approach: open or Video-assisted Thoracoscopic Surgery (VATS) lobectomy

Exclusion Criteria:

  1. Serious physical diseases in patients during hospitalization, such as severe heart and lung diseases (CLASS III-IV) (FEV1/FVC <0.7and FEV1 <50% predicted value), kidney disease (ESRD change need to continue dialysis), or liver diseases (cirrhosis of the liver accompanied by ascites)
  2. unable to obey interventional instructions/treatments because of any reasons
  3. stage IV lung cancer
  4. emergency surgery
  5. lung cancer with preoperative chemotherapy, radiotherapy or chemoradiotherapy

Sites / Locations

  • Ruijin Hospital, Shanghai JiaoTong University School of MedicineRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Experimental

Arm Label

regular care

pulmonary rehabilitation

Arm Description

[Control group] preoperative treatment: smoking cession, aerosol inhalation for expectorant and antiasthmatic, anti-infection therapy if necessary and regular rehabilitation-propaganda; postoperative treatment: regular postoperative treatment (anti-infection, pain control, oxygen Inhalation aerosol inhalation for expectorant and antiasthmatic), patting back (3 times/day, 15min/time) and early ambulation unless serious patients.

[Study group] preoperative treatment: smoking cession, aerosol inhalation for expectorant and antiasthmatic, anti-infection therapy if necessary, regular rehabilitation-propaganda and interventional pulmonary rehabilitation (preoperative part); postoperative treatment: regular postoperative treatment (anti-infection, pain control, oxygen Inhalation aerosol inhalation for expectorant and antiasthmatic), patting back (3 times/day, 15min/time), early ambulation unless serious patients and interventional pulmonary rehabilitation (postoperative part).

Outcomes

Primary Outcome Measures

postoperative pulmonary complications

Secondary Outcome Measures

length of stay (LOS)
therapeutic time of antibiotics
arterial blood gas analysis
vital signs
pain score of expectoration
Visual Analogue Scale (VAS) Pain Score
amount of expectoration drainage
peak expiratory flow
lung function test
total hospitalization expenditures

Full Information

First Posted
December 26, 2016
Last Updated
October 7, 2021
Sponsor
Ruijin Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT03010033
Brief Title
Effect of Pulmonary Rehabilitation on Perioperative Outcomes in Smoker Patients With Lung Cancer
Acronym
PREPOSE
Official Title
Effects of Pulmonary Rehabilitation and Airway Management on Short-term and Long-term Perioperative Results of Lobectomy in Smoker Patients With Lung Cancer
Study Type
Interventional

2. Study Status

Record Verification Date
October 2021
Overall Recruitment Status
Unknown status
Study Start Date
January 20, 2017 (Actual)
Primary Completion Date
September 2022 (Anticipated)
Study Completion Date
December 2022 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Ruijin Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
It is reported that smoker patients (>400 cigarette/year) will suffer more postoperative complications than non-smoker patients after lobectomy. Evidences has suggested pulmonary rehabilitation could reduce the pulmonary complications after thoracic surgery. However, the effect and long-term results of pulmonary rehabilitation on smoker patients have not been studied. The purpose of this study is to determine whether pulmonary rehabilitation is effective to smoker patients who underwent lobectomy.
Detailed Description
In China, the smoker population is about 300 hundred million. Tobacco has become one of the world's public health problem. 30 percent of global surgery patients have smoking history. It is reported that smoker patients (>400 cigarette/year) will suffer more postoperative complications than non-smoker patients after lobectomy (38.2% vs 12.5%). Smoking is an independent risk factor of postoperative complications of cardiothoracic surgery. Evidences showed that smoking had a negative effect on airway management which plays an important role in postoperative recovery for thoracic surgery. Therefore, we hypothesise that intervention-related study to find a way to reduce postoperative complications for smoker patients is significantly meaningful in improving the overall outcome after pulmonary surgery as 80 percent of patients with lung cancer are smoker in China. Recently, a series of strategies on airway management have been proposed by clinical doctors. As one of the important parts of airway management, pulmonary rehabilitation has been demonstrated by evidence-base medicine to reduce the pulmonary complications after thoracic surgery and increase the breathing capacity. According to the reported literatures, the effect and long-term results of pulmonary rehabilitation on smoker patients have not been studied, so we designed this randomized controlled trial to determine whether pulmonary rehabilitation would be effective to smoker patients who underwent lobectomy which was associated with significant loss of lung function. According to the reported papers in China, main observation index in experimental group was about 25.7, and in control group was about 10%. At the level of α=0.05 (Bilateral), power of test (1-β)=0.80, ratio=1:1. The estimated minimum required sample size of each group was 93 cases, the statistical loss rate was set as 10%. The overall sample size of this study was about 200 cases.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pulmonary Neoplasm
Keywords
pulmonary rehabilitation, lobectomy, smoker

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
200 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
regular care
Arm Type
No Intervention
Arm Description
[Control group] preoperative treatment: smoking cession, aerosol inhalation for expectorant and antiasthmatic, anti-infection therapy if necessary and regular rehabilitation-propaganda; postoperative treatment: regular postoperative treatment (anti-infection, pain control, oxygen Inhalation aerosol inhalation for expectorant and antiasthmatic), patting back (3 times/day, 15min/time) and early ambulation unless serious patients.
Arm Title
pulmonary rehabilitation
Arm Type
Experimental
Arm Description
[Study group] preoperative treatment: smoking cession, aerosol inhalation for expectorant and antiasthmatic, anti-infection therapy if necessary, regular rehabilitation-propaganda and interventional pulmonary rehabilitation (preoperative part); postoperative treatment: regular postoperative treatment (anti-infection, pain control, oxygen Inhalation aerosol inhalation for expectorant and antiasthmatic), patting back (3 times/day, 15min/time), early ambulation unless serious patients and interventional pulmonary rehabilitation (postoperative part).
Intervention Type
Other
Intervention Name(s)
pulmonary rehabilitation
Intervention Description
pulmonary rehabilitation (preoperative part): lower extremity endurance training (using bike ergometer for 3 days, 2 times/day, 15-20min/time) or stair climbing training (3 days, 2 times/day, 30min/time), keep dyspnea index (Borg) score between 5 to 7 points. And inspiratory muscle training (using threshold inspiratory muscle trainer for 3 days, 5 times/day, 2 sessions/time, every session includes 10-20 cycle respirations). pulmonary rehabilitation (postoperative part): inspiratory muscle training (using threshold inspiratory muscle trainer until hospital discharge, 3-5 times/day, 1 session/time, every session includes 10-20 cycle respirations).
Primary Outcome Measure Information:
Title
postoperative pulmonary complications
Time Frame
postoperative in-hospital stay up to 30 days
Secondary Outcome Measure Information:
Title
length of stay (LOS)
Time Frame
postoperative in-hospital stay up to 90 days
Title
therapeutic time of antibiotics
Time Frame
Postoperative in-hospital stay up to 30 days
Title
arterial blood gas analysis
Time Frame
before treatment, 3 days after treatment, 1 day after surgery, 3 days after surgery
Title
vital signs
Time Frame
before treatment, 3 days after treatment, 1 day after surgery, 3 days after surgery
Title
pain score of expectoration
Description
Visual Analogue Scale (VAS) Pain Score
Time Frame
1 day and 3 days after surgery
Title
amount of expectoration drainage
Time Frame
postoperative in-hospital stay up to 30 days
Title
peak expiratory flow
Time Frame
before treatment, 3 days after treatment, 1 day after surgery, 3 days after surgery
Title
lung function test
Time Frame
before treatment, 3 days after surgery, 3 months after surgery, 6 months after surgery
Title
total hospitalization expenditures
Time Frame
postoperative in-hospital stay up to 30 days

10. Eligibility

Sex
All
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: signed consent smoker, ≥400/cigarette year surgical approach: open or Video-assisted Thoracoscopic Surgery (VATS) lobectomy Exclusion Criteria: Serious physical diseases in patients during hospitalization, such as severe heart and lung diseases (CLASS III-IV) (FEV1/FVC <0.7and FEV1 <50% predicted value), kidney disease (ESRD change need to continue dialysis), or liver diseases (cirrhosis of the liver accompanied by ascites) unable to obey interventional instructions/treatments because of any reasons stage IV lung cancer emergency surgery lung cancer with preoperative chemotherapy, radiotherapy or chemoradiotherapy
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Ding-Pei Han, master
Phone
00862164370045
Ext
666112
Email
dmhan1985@163.com
First Name & Middle Initial & Last Name or Official Title & Degree
He-Cheng Li, doctor
Phone
00862164370045
Ext
666112
Email
lihecheng2000@163.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
He-Cheng Li, doctor
Organizational Affiliation
Ruijin Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Ruijin Hospital, Shanghai JiaoTong University School of Medicine
City
Shanghai
State/Province
Shanghai
ZIP/Postal Code
021
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ding-Pei Han, master
Phone
00862164370045
Ext
666112
Email
dmhan1985@163.com
First Name & Middle Initial & Last Name & Degree
He-Cheng Li, doctor
Phone
00862164370045
Ext
666112
Email
lihecheng2000@163.com
First Name & Middle Initial & Last Name & Degree
Ding-Pei Han, master
First Name & Middle Initial & Last Name & Degree
Run-Sen Jin, doctor
First Name & Middle Initial & Last Name & Degree
Ya-Jie Zhang, doctor
First Name & Middle Initial & Last Name & Degree
Jie Xiang, bachelor
First Name & Middle Initial & Last Name & Degree
Kai Chen, master
First Name & Middle Initial & Last Name & Degree
Hai-Lei Du, master
First Name & Middle Initial & Last Name & Degree
Jia-Ming Che, bachelor
First Name & Middle Initial & Last Name & Degree
Jun-Biao Hang, bachelor
First Name & Middle Initial & Last Name & Degree
Liang-Gang Zhu, master
First Name & Middle Initial & Last Name & Degree
Xiao-Qing Yang, master
First Name & Middle Initial & Last Name & Degree
Xiang Zhou, master
First Name & Middle Initial & Last Name & Degree
Jian Ren, bachelor

12. IPD Sharing Statement

Learn more about this trial

Effect of Pulmonary Rehabilitation on Perioperative Outcomes in Smoker Patients With Lung Cancer

We'll reach out to this number within 24 hrs